In addition, it was previously reported that adiponectin has a vasoprotective effect and might be recommended as a potential vascular marker for the inhibition of and protection against many metabolic disorders, such as type 2 diabetes, obesity, and atherosclerosis [94–98]. Here, ADIPOQ is linked to type 2 diabetes mellitus.